Announcements
Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Open Access
Erratum
Correction to “The Potential Role of Anti-PCSK9 Monoclonal Antibodies in the Management of Hypercholesterolemia”
Show Less
1
The David Geffen School of Medicine at UCLA and Cedars-Sinai Medical Center, Los Angeles, CA
2
Westside Medical Associates of Los Angeles, Beverly Hills, CA
3
The Christ Hospital Heart and Vascular Center, The Lindner Research Center, Cincinnati, OH
Rev. Cardiovasc. Med. 2015, 16(1), 94–94;
https://doi.org/10.3909/ricm0773corr
Published: 30 March 2015
Abstract
The support statement for Lepor NE et al, “The potential role of anti-PCSK9 monoclonal antibodies in the management of hypercholesterolemia,” Rev Cardiovasc Med. 2014;15(4):290-309, was incorrectly attributed. This activity is supported by an educational grant from sanofi-aventis U.S. and Regeneron Pharmaceuticals. The corrected article appears overleaf with its original pagination.